[HTML][HTML] Inhibition of mutated, activated BRAF in metastatic melanoma
Background The identification of somatic mutations in the gene encoding the serine–
threonine protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to …
threonine protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to …
[HTML][HTML] Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
KT Flaherty, I Puzanov, KB Kim, A Ribas… - The New England …, 2010 - ncbi.nlm.nih.gov
Background The identification of somatic mutations in the gene encoding the serine–
threonine protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to …
threonine protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to …
[引用][C] Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
KT FLAHERTY, I PUZANOV… - The New England …, 2010 - pascal-francis.inist.fr
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
[PDF][PDF] Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
KT Flaherty, I Puzanov, KB Kim, A Ribas… - N Engl J …, 2010 - researchgate.net
Abstract From the Abramson Cancer Center of the University of Pennsylvania, Philadelphia
(KTF, PJO); Massachusetts General Hospital Cancer Center, Boston (KTF); Vanderbilt …
(KTF, PJO); Massachusetts General Hospital Cancer Center, Boston (KTF); Vanderbilt …
[PDF][PDF] Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
KT Flaherty, I Puzanov, KB Kim, A Ribas… - N Engl J Med, 2010 - academia.edu
Abstract From the Abramson Cancer Center of the University of Pennsylvania, Philadelphia
(KTF, PJO); Massachusetts General Hospital Cancer Center, Boston (KTF); Vanderbilt …
(KTF, PJO); Massachusetts General Hospital Cancer Center, Boston (KTF); Vanderbilt …
Inhibition of mutated, activated BRAF in metastatic melanoma.
KT Flaherty, I Puzanov, KB Kim, A Ribas… - The New England …, 2010 - europepmc.org
Background The identification of somatic mutations in the gene encoding the serine-
threonine protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to …
threonine protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to …
[PDF][PDF] Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
KT Flaherty, I Puzanov, KB Kim, A Ribas, GA McArthur… - N Engl J Med, 2010 - piel-l.org
Abstract From the Abramson Cancer Center of the University of Pennsylvania, Philadelphia
(KTF, PJO); Massachusetts General Hospital Cancer Center, Boston (KTF); Vanderbilt …
(KTF, PJO); Massachusetts General Hospital Cancer Center, Boston (KTF); Vanderbilt …
[引用][C] Inhibition of mutated, activated BRAF in metastatic melanoma
F KT - N Engl J Med, 2010 - cir.nii.ac.jp
Inhibition of mutated, activated BRAF in metastatic melanoma
KT Flaherty, I Puzanov, KB Kim… - The New England …, 2010 - pubmed.ncbi.nlm.nih.gov
Background The identification of somatic mutations in the gene encoding the serine-
threonine protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to …
threonine protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to …
Inhibition of mutated, activated BRAF in metastatic melanoma
KT Flaherty, I Puzanov, KB Kim… - New England …, 2010 - scholars.northwestern.edu
Background: The identification of somatic mutations in the gene encoding the serine-
threonine protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to …
threonine protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to …